Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Other Non-Current Liabilities (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $132000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities changed N/A to $132000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $132000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $132000.0 for FY2025, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $132000.0 at Adagio Medical Holdings, down from $486000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $3.6 million in Q2 2025, with the low at $8000.0 in Q4 2023.
  • Average Other Non-Current Liabilities over 3 years is $1.1 million, with a median of $309000.0 recorded in 2025.
  • Peak annual rise in Other Non-Current Liabilities hit 80.28% in 2025, while the deepest fall reached 80.28% in 2025.
  • Over 3 years, Other Non-Current Liabilities stood at $8000.0 in 2023, then skyrocketed by 30712.5% to $2.5 million in 2024, then tumbled by 94.65% to $132000.0 in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $132000.0, $486000.0, and $3.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.